NPPA approves price rise of 50 per cent for carbamazepine, ranitidine, ibuprofenNPPA, in its meeting on June 28, deliberated upon the case of upward price revision of the formulations of these drugs under Para 19 of DPC...
Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...
Government forms panel to make drugs more affordableThe committee would also review the scope of Drugs (Price Control) Order 2013 (DPCO 2013) and suggest ways for strengthening the regulatory...
Medical devices notified as drugs must carry printed MRP: NPPAThese devices are non-scheduled formulations and their sales are governed by the provisions of DPCO 2013, the notification said.
NPPA seeks info about pricing, products from stent makersThe National Pharmaceutical Pricing Authority (NPPA) has also called for a meeting with the stakeholders to discuss the issue on January 24.
Fixing drug prices helped consumers save Rs 5,060 crore: GovernmentAs per the provisions of the DPCO 2013, to control the prices of essential medicines, NPPA has fixed the prices of medicines appearing in S...
Fixing drug prices helped consumers save Rs 5,000 crore: Government"The total saving to consumers as a result of price control under DPCO 2013 is nearly Rs 4,988 crore," Kumar said.
NPPA issues notices to drug companies over violations of DPCO 2013NPPA has issued notices to major drug firms for failing to register products on online database IPDMS and not filing mandatory returns thro...
Drug price regulator finds 4,700 medicines illegally over-pricedThe national drug price regulator NPPA has warned of action against companies violating its pricing norms as it found prices of more than 4...
Drug price cut yielded Rs 2,772 crore benefit to public: GovernmentAll the NLEM 2011 medicines have been included in the first schedule of DPCO, 2013, and brought under price control.
NPPA exempts price controls for three insulins of WockhardtIndia’s drug pricing watchdog, the National Pharmaceutical Pricing Authority (NPPA), has exempt drug maker Wockhardt’s three insulin produc...
Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
Government decision to cap condom prices illegal: Delhi HCDelhi High Court today held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the lu...
NPPA seeks details of price movement of certain ortho implantsNPPA has sought details from some medical device companies regarding the price movement of certain orthopaedic implants in last three years.
NPPA asks drug makers to register for online databaseNational drug pricing regulator NPPA has asked all pharmaceutical firm to register themselves under the IPDMS for online filing of returns.
Pharma industry hit by worst slowdown in the domestic market for the month of AugustThe Indian pharma industry, while being on a roll due to the higher export realisations due to the weaker rupee, has suffered badly in the ...
Firms need to give 6 months notice to stop essential drugsThe government can ask the manufacturers to continue to produce required level of essential drugs, read Drug Price Control Order.